Newborn screening for congenital adrenal hyperplasia in Wisconsin.
Beginning in February 1993, newborn screening for 21-hydroxylase deficiency congenital adrenal hyperplasia (21OH-D-CAH) will begin in Wisconsin. This brief review summarizes the pathophysiology of 21OH-D-CAH, its clinical presentation, and the rationale for screening during the neonatal period. An algorithm for interpretation and follow-up of screening results is provided for Wisconsin health care providers.